Business

Standard principle for product development

Basic policy for product development

Our research and development team aims to provide products useful for patients and consumers worldwide, by leveraging the latest medical evidence and collaboration with local and international research groups (see "Clinical Study Information”).
In addition, our state-of-the-art research facilities are fully equipped to conduct not only basic research but also the manufacturing of investigational drugs and prototype medical devices.

Supplement

サプリメント事業

Our supplement products are developed and manufactured based on the following principles.
We maintain at the highest level of transparency on the disclosure of quality information.

  • To ensure traceability (Country of origin of all ingredients, Certificate of Analysis)
  • Quality assurance of finished products
  • No additives (or very minimum quantity of excipients)
  • Appropriate dosage (based on clinical evidence of efficacy and safety)
  • Improved convenience (e.g., smaller number of capsules/tablets/dose)
  • Appropriate dosage form and primary containers/ packaging
  • Use of silica gel/deoxgenizen
  • Appropriate information sharing (e.g., most desirable use method)

We have focused on infertility but is now expanding to other health problems such as skin, pediatrics and elderly people.

New Drug Development

新薬開発事業

We have started new program to develop a new drug to improve a clinical pregnancy rate in women undergoing ART.
Through collaboration with universities, we strive to develop the first in class new drug in the area of infertility. Once patent filing was completed, more information will be disclosed.
We will do our best so that this project will become a gospel for those suffering from infertility.

Clinical Investigations

We are actively conducting clinical studies with universities and clinics.